Index by author
September 01, 2006; Volume 58,Issue 3
A
Abbracchio, Maria P.
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
B
Barnard, Eric A.
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Bátkai, Sándor
- You have accessThe Endocannabinoid System as an Emerging Target of PharmacotherapyPál Pacher, Sándor Bátkai and George KunosPharmacological Reviews September 2006, 58 (3) 389-462; DOI: https://doi.org/10.1124/pr.58.3.2
Beavo, Joseph A.
- You have accessCyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical UseAndrew T. Bender and Joseph A. BeavoPharmacological Reviews September 2006, 58 (3) 488-520; DOI: https://doi.org/10.1124/pr.58.3.5
Begg, Evan J.
- You have accessPharmacogenetics, Drug-Metabolizing Enzymes, and Clinical PracticeSharon J. Gardiner and Evan J. BeggPharmacological Reviews September 2006, 58 (3) 521-590; DOI: https://doi.org/10.1124/pr.58.3.6
Bender, Andrew T.
- You have accessCyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical UseAndrew T. Bender and Joseph A. BeavoPharmacological Reviews September 2006, 58 (3) 488-520; DOI: https://doi.org/10.1124/pr.58.3.5
Boeynaems, Jean-Marie
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Boyer, José L.
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Brink, Charles
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
Burnstock, Geoffrey
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
C
Chapman, M. John
- You have accessFunctionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and AtherosclerosisAnatol Kontush and M. John ChapmanPharmacological Reviews September 2006, 58 (3) 342-374; DOI: https://doi.org/10.1124/pr.58.3.1
Chiang, Nan
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
Chou, Ting-Chao
- You have accessTheoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesTing-Chao ChouPharmacological Reviews September 2006, 58 (3) 621-681; DOI: https://doi.org/10.1124/pr.58.3.10
D
Dahlén, Sven-Erik
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
Drazen, Jeffrey M.
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
F
Farooqui, Akhlaq A.
- You have accessInhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic DisordersAkhlaq A. Farooqui, Wei-Yi Ong and Lloyd A. HorrocksPharmacological Reviews September 2006, 58 (3) 591-620; DOI: https://doi.org/10.1124/pr.58.3.7
Folco, Giancarlo
- You have accessEicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue ResponsesGiancarlo Folco and Robert C. MurphyPharmacological Reviews September 2006, 58 (3) 375-388; DOI: https://doi.org/10.1124/pr.58.3.8
Fumagalli, Marta
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
G
Gachet, Christian
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Gardiner, Sharon J.
- You have accessPharmacogenetics, Drug-Metabolizing Enzymes, and Clinical PracticeSharon J. Gardiner and Evan J. BeggPharmacological Reviews September 2006, 58 (3) 521-590; DOI: https://doi.org/10.1124/pr.58.3.6
H
Hay, Douglas W. P.
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
Horrocks, Lloyd A.
- You have accessInhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic DisordersAkhlaq A. Farooqui, Wei-Yi Ong and Lloyd A. HorrocksPharmacological Reviews September 2006, 58 (3) 591-620; DOI: https://doi.org/10.1124/pr.58.3.7
J
Jacobson, Kenneth A.
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
K
Kennedy, Charles
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Knight, Gillian E.
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Kontush, Anatol
- You have accessFunctionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and AtherosclerosisAnatol Kontush and M. John ChapmanPharmacological Reviews September 2006, 58 (3) 342-374; DOI: https://doi.org/10.1124/pr.58.3.1
Kunos, George
- You have accessThe Endocannabinoid System as an Emerging Target of PharmacotherapyPál Pacher, Sándor Bátkai and George KunosPharmacological Reviews September 2006, 58 (3) 389-462; DOI: https://doi.org/10.1124/pr.58.3.2
M
Murphy, Robert C.
- You have accessEicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue ResponsesGiancarlo Folco and Robert C. MurphyPharmacological Reviews September 2006, 58 (3) 375-388; DOI: https://doi.org/10.1124/pr.58.3.8
O
Ong, Wei-Yi
- You have accessInhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic DisordersAkhlaq A. Farooqui, Wei-Yi Ong and Lloyd A. HorrocksPharmacological Reviews September 2006, 58 (3) 591-620; DOI: https://doi.org/10.1124/pr.58.3.7
P
Pacher, Pál
- You have accessThe Endocannabinoid System as an Emerging Target of PharmacotherapyPál Pacher, Sándor Bátkai and George KunosPharmacological Reviews September 2006, 58 (3) 389-462; DOI: https://doi.org/10.1124/pr.58.3.2
R
Rovati, G. Enrico
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
S
Serhan, Charles N.
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
Shimizu, Takao
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
W
Weisman, Gary A.
- You have accessInternational Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyMaria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, José L. Boyer, Charles Kennedy, Gillian E. Knight, Marta Fumagalli, Christian Gachet, Kenneth A. Jacobson and Gary A. WeismanPharmacological Reviews September 2006, 58 (3) 281-341; DOI: https://doi.org/10.1124/pr.58.3.3
Y
Yokomizo, Takehiko
- You have accessThe Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in VivoNan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo and Charles BrinkPharmacological Reviews September 2006, 58 (3) 463-487; DOI: https://doi.org/10.1124/pr.58.3.4
In this issue
Advertisement